NCT06058923

Brief Summary

This is a 12-month longitudinal, double-blind, parallel-design randomized controlled clinical trial involving surgical therapeutic intervention (Phase 4). It will include 50 participants aged 21 diagnosed with periodontitis (Stage III/IV, Grade A or B), divided into a Test Group (n=25, Minimally invasive single-flap surgery) and a Control Group (n=25, Minimally invasive double-flap surgery). The objective of this randomized, double-blind clinical study is to compare clinical, radiographic, and patient-centered outcomes between minimally invasive single-flap and double-flap techniques in treating isolated infra-bony defects. Twenty-five patients will be treated using the single-flap approach, and 25 patients will receive the double-flap elevation technique. Clinical parameters (plaque and bleeding scores, probing depth, gingival recession, clinical attachment level, and papillary dimensions), digital measurements (changes in gingival margin and papillary volume), radiographic assessments, and patient-centered outcomes (VAS scale) will be evaluated immediately before surgery, at 6 and 12 months post-procedure, while early healing will be assessed after 1 and 2 weeks following the procedures. Mean values and standard deviations will be calculated for each variable, normal distribution will be tested using the Shapiro-Wilk test, and comparisons will be conducted using Student's t-test and one-way ANOVA. A significance level of 5% will be used for all analyses.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Aug 2023Jul 2026

Study Start

First participant enrolled

August 10, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 21, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2026

Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

2.9 years

First QC Date

September 21, 2023

Last Update Submit

January 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Probing Depth

    Reduction of Probing Depth

    6 months and 1 year

Secondary Outcomes (2)

  • Clinical Attachment Level

    6 months and 1 year

  • Subtraction Radiography

    1 year

Study Arms (2)

Minimally Invasive Surgical Technique (MIST)

ACTIVE COMPARATOR

Double flap minimally invasive surgery for the access of intrabony defects

Procedure: MIST

Modified Minimally Invasive Surgical Technique (M-MIST)

EXPERIMENTAL

Single flap minimally invasive surgery for the access of intrabony defects

Procedure: M-MIST

Interventions

M-MISTPROCEDURE

This is characterized by a vestibular mucoperiosteal envelope flap without relaxing incisions. Sulcular incisions will be made on the vestibular surface of the teeth included in the surgical area, adjacent to the infraosseous defect. The mesiodistal extension of the flap will be kept to a minimum necessary to access the defect. In the papillary area over the infraosseous defect, an oblique or horizontal incision will be made at the level of the interdental papilla, following the contour of the bone crest. The vestibular flap will be elevated, leaving the lingual/palatal portion adhered, only to allow access to the bone defect. The defect will be instrumented with mini-curettes and specific ultrasonic tips, and the defect will be filled only with a blood clot after this procedure. Primary closure will be achieved with internal vertical and/or horizontal mattress sutures, which may be complemented with simple sutures, all using specific suture threads.

Also known as: Minimally invasive single flap technique
Modified Minimally Invasive Surgical Technique (M-MIST)
MISTPROCEDURE

A vestibular envelope flap, without vertical relaxing incisions, will be raised on the vestibular and lingual/palatal sides. Primary intrasulcular incisions will be made to the alveolar crest, encompassing the teeth included in the surgical area. In the interproximal area, incisions will follow the principle of preserving the papilla (Modified Papilla Preservation Technique = MPPT or Simplified Papilla Preservation Flap = SPPF), depending on the available interproximal space (Cortellini et al., 1995, 1999). The mesiodistal extension of the flap will be minimized to provide adequate access to the defect. The defect will be instrumented using mini-curettes and specific ultrasonic tips, and the defect will be filled only with a blood clot after these procedures. Flap closure will be achieved with internal horizontal and/or vertical mattress sutures, which may be modified or complemented with simple sutures, all using specific suture threads.

Also known as: Minimally invasive double flap technique
Minimally Invasive Surgical Technique (MIST)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy individuals
  • Diagnosis of periodontitis (stage III/IV - grade A or B)
  • Presence of 20 or more teeth in the oral cavity
  • Presence of at least one isolated interproximal infra-bony defect (without extension of the defect to the lingual or palatal area - assessed with preoperative bone sounding), with a probing depth of 6 mm or more, and a radiographic infra-bony component ≥ 4 mm, not associated with bifurcation areas, in anterior or premolar teeth (Schincaglia et al., 2015)
  • Plaque index and bleeding on probing index ≤ 20% (baseline)
  • Individuals providing informed and voluntary consent

You may not qualify if:

  • Individuals who are not available for study evaluation appointments
  • Systemic conditions that contraindicate periodontal surgery
  • Patients requiring prophylactic antibiotics
  • Compromised systemic condition (leukocyte dysfunction, bleeding disorders, neoplasms, uncontrolled metabolic or endocrine disorders, HIV infection)
  • Individuals using bisphosphonates (oral or injectable use)
  • Individuals using antibiotics and steroids (within 6 months prior to the study start)
  • Illicit drug users
  • Smokers
  • Individuals with the tooth associated with the infra-bony defect having inadequate restoration, endodontic lesion, inadequate endodontic treatment, untreated carious lesions, and Grade III mobility
  • Pregnant and lactating Women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piracicaba Dental School, State University of Campinas

Piracicaba, São Paulo, 13414903, Brazil

Location

MeSH Terms

Conditions

PeriodontitisChronic Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Thais FM Paschoal, MsC

    University of Campinas, Brazil

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled double-blind parallel-design clinical trial with a longitudinal duration of 12 months per participant, involving surgical therapeutic intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Chair of Periodontology Area

Study Record Dates

First Submitted

September 21, 2023

First Posted

September 28, 2023

Study Start

August 10, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 10, 2026

Last Updated

January 23, 2026

Record last verified: 2026-01

Locations